tert-Butyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbonate, 95.0%, 5g

4-Bromo-5-nitroveratrole, 98.0%, 250mg

1-[5-chloro-2-(difluoromethoxy)phenyl]ethan-1-one, 95%, 10g

Seringue microlitre GASTIGHT® série 1700 Point type 3, 50 µl, 1705 RNR, 1 pièce

2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)benzonitrile, 95.0%, 5g

Potassium (Acetoxymethyl)trifluoroborate>96.0%(T)1g

Fmoc-Pro-OH, 98%, 1kg

4-BOC-1,4-Oxazepane-6-carboxylic acid, 95.0%, 250mg

1-Bromo-3-methylnaphthalene, 95.0%, 1g

(2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-benzylpyrrolidine-2-carboxylic acid, 95%, 100mg

Ethyl 4-fluoro-1H-indole-7-carboxylate, 97%, 250mg

2-(AZETIDIN-3-YL)-2-METHYLPROPANENITRILE TFA, 95.0%, 500mg

(4-(tert-Butyl)phenyl)(imino)(methyl)-l6-sulfanone, 100mg